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Abstract 
Primary  cerebral  rhabdomyosarcomas  are
very rare and malignant tumors that occur pre-
dominantly in the posterior fossa of pediatric
patients. We report a rare case of primary cere-
bral rhabdomyosarcoma located in the supra-
tentorial compartment of a 51 year-old woman
together with a review of the pertinent litera-
ture especially regarding the histological diag-
nosis and pitfalls.
Introduction
Primary  cerebral  rhabdomyosarcomas
(PCR), defined as pure mesenchymal tumors
composed by both embryonal and mature stri-
ated muscle cells, are very rare malignant neo-
plasms  that  bear  a  poor  prognosis.1-3 In  the
pediatric  population  they  are  preferentially
located  in  the  infratentorial  compartment.
Only sporadic cases are described in adults.
Treatment  for  these  lesions  is  not  yet  stan-
dardized, but maximal safe resection followed
by  radiation  therapy  is  widely  suggested,
whereas the role of chemotherapy is still dis-
cussed.1,4-6 We report the case of a 51 year-old
woman,  affected  by  supratentorial  primary
cerebral  rhabdomyosarcoma,  treated  with
gross-total  surgical  resection  and  adjuvant
radiation  treatment  initially  and  followed  by
radioimmunotherapy thereafter, along with a
review of the literature on adult primary cere-
bral rhabdomyosarcomas.
Case Report
A 51 year-old woman was admitted to our
hospital complaining of a persistent headache
developed  over  a  few  days.  Her  neurologic
examination  revealed  only  a  moderate  right
hemiparesis  with  sensory  disturbances.  A
brain CT scan displayed a 5-cm-diameter solid-
cystic lesion in the left parietal lobe. Magnetic
resonance imaging (MRI) confirmed the pres-
ence of a right-sided parietal intra-axial mass
with a cystic component, a heterogeneous iso-
hypointense  signal  on  T1-weighted  images
and a heterogeneous hyperintense signal on
T2-weighted  images  of  the  solid  portion
(Figure  1a),  enhancing  after  Gadolinium
administration  (Figure  1b).  The  tumor  was
gross-totally  removed  (with  a  post-operative
confirmation of the MRI that did not show any
sign of contrast enhancement) through a left
parietal craniotomy with the aid of neuronavi-
gation  and  neurophysiological  intraoperative
monitoring of the motor function. The tumor
was gray, soft and apparently well demarcated
from the surrounding brain. The cystic portion
contained  a  transparent  yellowish  fluid.  Its
global  intraoperative  aspect  was  that  of  a
metastatic lesion. 
Microscopic examination showed a malig-
nant lesion composed by small cells with elon-
gated  nuclei  arranged  in  irregular  fascicles,
mixed with multinucleated giant cells with an
intense  mitotic  activity  and  focal  necrosis
(Figure 2a). The lesion appeared highly vascu-
larized.  Immunohistochemical  analysis
revealed a focal positivity to GFAP and synapto-
physin,  together  with  a  60%  positivity  to
vimentin  and  90%  to  desmin  (in  this  latter
case  sometimes  with  a  perinuclear  dot-like
pattern).  Staining  for  cytokeratin,  epithelial
membrane  antigen  (EMA),  CD99  and  CD45
were  negative.  After  an  initial  diagnosis  of
small-cell glioblastoma, the pathologist consid-
ered the hypothesis of a secondary localization
of  pulmonary  microcytoma.  A  staging  chest
and abdomen-CT scan were negative and so
were blood levels for neuron-specific enolase
(NSE). A new and more detailed pathological
examination  was  therefore  performed.
Neoplastic cells resulted positive for myogenin
(Figure 2b) and muscle-specific actin. A final
diagnosis  of  cerebral  rhabdomyosarcoma  of
the alveolar type (since the microscopic archi-
tectural appearance of lining-up along pseudo-
spaces  that  are  reminiscent  of  lung  alveoli)
was  made.  Staging  confirmed  the  primary
source of the disease and the definitive diag-
nosis was primary cerebral rhabdomyosarco-
ma.  Our  patient  received  adjuvant  external
radiation  therapy  (with  the  same  standard
technique used for high-grade gliomas) for a
total dose of 60 Gy (2 Gy fractions) and refused
chemotherapy. After 11 months a local recur-
rent  tumor  with  the  same  neuroradiological
features of the neoplasm previously removed
was displayed after MRI. Given the good per-
formance status of the patient, a new surgical
procedure  was  undertaken,  but  the  lesion
recurred  in  less  than  four  months.  A  third
craniotomy  was  performed  and  a  Rickham’s
reservoir  was  left  in  the  tumor  cavity  for
radioimmunotherapy.  She  died  after  20
months from diagnosis.
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Figure 1. (a) Magnetic resonance imaging
scan of the head showing the radiological
appearance of left-sided parietal primary
rhabdomyosarcoma  on  T2-weighted  and
(b) T1-weighted images after Gadolinium
administration 
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Discussion
Primary cerebral rhabdomyosarcoma (PCR)
is extremely rare and occurs almost exclusive-
ly in the pediatric age group.1,3-5,7,8 To the best
of our knowledge, only 9 cases (including our
patient) of adult PCR were described in the
English-speaking  literature,1,4-6,9-12 and  for
some authors it represents a distinct entity. In
adult cases patient ages ranged from 24 to 68
years  (mean  47.1  years)  without  a  gender
predilection (4 males and 5 females). While in
the pediatric population PCR is mainly situat-
ed in the infratentorial compartment, in adults
there is a tendency to supratentorial localiza-
tion (7 out of 9 cases) (Table 1). 
This tumor has no distinguishing imaging
features  from  other  primary  or  secondary
malignant brain neoplasms.1 The typical MRI
appearance is that of a iso-hypointense lesion
on T1-weighted images and hyperintense on
T2-weighted  images,  most  commonly  with
poorly defined margins and an intense but het-
erogeneous  enhancement  after  Gadolinium
administration. Sometimes this neoplasm may
have  a  cystic  component  (as  in  our  case)
and/or  an  hemorrhagic  presentation.
Differential  diagnosis  should  include  high-
grade  glioma,  lymphoma,  metastases  and
PNET.  Histological  confirmation  is  essential
for the definitive diagnosis.1,4-6,9
Rhabdomyosarcomas  constitute  a  unique
group of soft tissue neoplasms that share a
propensity  to  undergo  myogenesis,  a  well-
defined biologic process that primarily occurs
during embryonal and fetal development. The
most diffuse pathological classification identi-
fies four subtypes: embryonal, alveolar, boty-
roid and pleomorphic.3 A primary involvement
of the brain has to be differentiated from an
intracranial  extension  from  skull  or  para-
menigeal sites (orbit, nasopharynx, paranasal
sinuses, middle ear, external auditory canal),
but also from a metastatic seeding from a sys-
temic rhabdomyosarcoma and from mixed pri-
mary cerebral tumors of the central nervous
system in which rhabdomyoblastic areas are
found in combination with sarcomatous, neu-
roectodermal,  mesenchimal  or  teratomatous
features.1 PCR consists primarily of small cells
that show little or no specific differentiation at
the  hematoxylin-eosin  level.  Thus,  immuno-
histochemistry and/or electron microscopy are
necessary for diagnosis, particularly immunos-
tains  for  desmin  and  myogenin.3,7,8 Histolo  -
gically, PCR must be differentiated from other
brain tumors that occasionally show skeletal
muscle  elements,  such  as  medullomyoblas-
tomas,  gliosarcomas,  germ  cell  tumors  and
even rare meningiomas. Histogenesis of this
rare  mesodermal  tumour  is  still  matter  of
debate. Some Authors concluded that it arises
from  pluripotential  cells  misplaced  during
embryonic life. An origin from primitive neural
crest cells that have undergone mesoectoder-
mal differentiation is also considered a possi-
bility.  These  undifferentiated  mesenchymal
cells  are  normally  described  in  pericapillary
locations, particularly in the pia mater.1,3-7)
The aim of treatment should be gross-total
surgical  resection,  followed  by  radiotherapy
and/or  chemotherapy,  both  in  pediatric  and
adult  PCRs.  As  for  our  case,  we  achieved  a
macroscopically complete surgical removal of
the lesion, as confirmed by post-operative MRI.
In the vast majority of cases radiation therapy
is the adjuvant treatment of choice, with a total
dose and fractionation similar to what is used
for malignant gliomas. In fact, for our patient a
total dose of 60 Gy in 30 fractions was admin-
istered. There is no consensus regarding the
role, or type, of chemotherapy. Relatively good
results were reported after the administration
of  VAC  (vincristine,  actinomycin  D  and
cyclophosphamide) or ICE (ifosfamide, carbo-
platin and etoposide). Despite modern surgical
techniques  and  adjuvant  oncological  treat-
ments, PCR is associated with an extremely
poor prognosis, as reported in the Literature,
where survival is almost always less than 12
months with only few patients alive after 24
months.1,4-6,9-12
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S, subtotal removal; GT, gross-total removal; C, chemotherapy; R, radiotherapy; RI, radioimmunotherapy
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